About Us
About Guard Therapeutics
Vision, mission & goal
The Board
Management
Research & Development
Acute kidney injury
RMC-035 (ROSgard)
Clinical development
Patents
Investor Relations
Financial calender
Financial reports
Share information
Corporate governance
General meetings
News & Media
Press releases
Event calender
Analyses and presentations
In media
Subscribe
Contact
Swe
Search
Analyses and presentations
Analyses
Guard Therapeutics currently has analyst coverage by Danske Bank and Erik Penser Bank.
20 Sep 2023 / Erik Penser Bank - Guard Analysis 20 September 2023
https://guardtherapeutics.com/assets/uploads/Penser20230920-eng.pdf
Presentations & Interviews
30 Jan 2024 / Guard Therapeutics R&D update January 30, 2024
https://youtube.com/live/Enob5jUFw8I
23 Nov 2023 / Tobias Agervald presents at ABGSC Investor Days
https://www.youtube.com/watch?v=e2-bDLGMznk&list=PLgLifPc-PiGOhe-TjD_5jry8sc-EVJAoK&index=38
19 Sep 2023 / Presentation from Investor Webcast - AKITA Top-line results
https://guardtherapeutics.com/assets/uploads/Webcast-presentation-top-line-results_19-Sept-2023.pdf
19 Sep 2023 / Investor webcast: CEO Tobias Agervald and CMO Michael Reusch presents AKITA Top-line results
https://financialhearings.com/event/47345
30 May 2023 / ABGSC Life Science Summit
https://www.youtube.com/watch?v=3v1D6BU75S8
09 Nov 2022 / CEO interview following Fast Track designation (November 09, 2022)
https://youtu.be/cess3o77SGg